Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
Sub-Cellular Biochemistry
|
August 30, 2008
Fatty acid synthase activity in tumor cells
Joy L Little, Steven J Kridel
Expert Opinion on Investigational Drugs
|
November 1, 2007
Fatty acid synthase inhibitors: new directions for oncology
Steven J Kridel, W Todd Lowther, Charles W Pemble
Current Pharmaceutical Biotechnology
|
April 20, 2013
The potential of ¹¹C-acetate PET for monitoring the Fatty acid synthesis pathway in Tumors
Laura M Deford-Watts, Akiva Mintz, Steven J Kridel
Cancer Research
|
March 18, 2004
Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity
Steven J Kridel, Fumiko Axelrod, Natasha Rozenkrantz, et al.
Molecular Cancer Therapeutics
|
December 17, 2008
Disruption of crosstalk between the fatty acid synthesis and proteasome pathways enhances unfolded protein response signaling and cell death
Joy L Little, Frances B Wheeler, Constantinos Koumenis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 18, 2008
1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer
Amy L Vāvere, Steven J Kridel, Frances B Wheeler, et al.
Cancer Metastasis Reviews
|
October 22, 2011
Polyunsaturated fatty acid metabolism in prostate cancer
Isabelle M Berquin, Iris J Edwards, Steven J Kridel, et al.
Nature Structural & Molecular Biology
|
July 10, 2007
Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat
Charles W Pemble, Lynnette C Johnson, Steven J Kridel, et al.
Oncotarget
|
April 16, 2016
Palmitoylation regulates the intracellular trafficking and stability of c-Met
David T Coleman, Alana L Gray, Steven J Kridel, et al.
Plos One
|
July 7, 2012
Nicotinamide phosphoribosyl transferase (Nampt) is required for de novo lipogenesis in tumor cells
Sarah C Bowlby, Michael J Thomas, Ralph B D'Agostino, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
Sub-Cellular Biochemistry
|
August 30, 2008
Fatty acid synthase activity in tumor cells
Joy L Little, Steven J Kridel
Expert Opinion on Investigational Drugs
|
November 1, 2007
Fatty acid synthase inhibitors: new directions for oncology
Steven J Kridel, W Todd Lowther, Charles W Pemble
Current Pharmaceutical Biotechnology
|
April 20, 2013
The potential of ¹¹C-acetate PET for monitoring the Fatty acid synthesis pathway in Tumors
Laura M Deford-Watts, Akiva Mintz, Steven J Kridel
Cancer Research
|
March 18, 2004
Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity
Steven J Kridel, Fumiko Axelrod, Natasha Rozenkrantz, et al.
Molecular Cancer Therapeutics
|
December 17, 2008
Disruption of crosstalk between the fatty acid synthesis and proteasome pathways enhances unfolded protein response signaling and cell death
Joy L Little, Frances B Wheeler, Constantinos Koumenis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 18, 2008
1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer
Amy L Vāvere, Steven J Kridel, Frances B Wheeler, et al.
Cancer Metastasis Reviews
|
October 22, 2011
Polyunsaturated fatty acid metabolism in prostate cancer
Isabelle M Berquin, Iris J Edwards, Steven J Kridel, et al.
Nature Structural & Molecular Biology
|
July 10, 2007
Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat
Charles W Pemble, Lynnette C Johnson, Steven J Kridel, et al.
Oncotarget
|
April 16, 2016
Palmitoylation regulates the intracellular trafficking and stability of c-Met
David T Coleman, Alana L Gray, Steven J Kridel, et al.
Plos One
|
July 7, 2012
Nicotinamide phosphoribosyl transferase (Nampt) is required for de novo lipogenesis in tumor cells
Sarah C Bowlby, Michael J Thomas, Ralph B D'Agostino, et al.
Page
of 3